Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment

FDA‐approved anti‐parasite drug ivermectin is also an antibacterial, antiviral, and anticancer agent, which offers more potentiality to improve global public health, and it can effectively inhibit the replication of SARS‐CoV‐2 in vitro.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7536980/

Subscribe to Our Newsletter

Stay connected with reflections on faith, reason, and life.

No spam. Unsubscribe anytime.

We don’t spam! Read our privacy policy for more info.

Share Your Thoughts